Chad Therapeutics Posts Net Loss for 1st Quarter

Chad Therapeutics Inc., Chatsworth, announced a net loss of $154,000 for the first quarter ended June 30, compared with net earnings of $107,000 for the same quarter last year. Sales fell 13% to $3.6 million, compared with $4.2 million.

Chad produces and distributes supplemental oxygen systems and conservation devices for pulmonary patients.